Skip to main content
Clinical Trials/TCTR20180914001
TCTR20180914001
Completed
Phase 1

Risk factors for a high comprehensive complication index (CCI) after splenectomy plus pericardial devascularization for portal hypertension

Yiming Li0 sites659 target enrollmentSeptember 14, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
To compare evaluations of complications between the novel CCI and the conventional CDC for portal hypertension (PH) patients who underwent splenectomy plus pericardial devascularization (SPD) and to i
Sponsor
Yiming Li
Enrollment
659
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2018
End Date
May 2, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Yiming Li

Eligibility Criteria

Inclusion Criteria

  • (1\) PH patients with a history of upper gastrointestinal bleeding; (2\) PH patients diagnosed with esophagogastric varices and hypersplenism through clinical symptoms combined with laboratory, digestive endoscopy or image examinations; (3\) PH patients classified as grade A or B in the Child\-Pugh grading criteria or who were reduced to Child\-Pugh A or B after liver preservation therapy to attain surgical indications; and (4\) patients who could tolerate general anesthesia and had no surgical contraindications.

Exclusion Criteria

  • (1\) patients with acute heart failure, shock, or other vital organ diseases; (2\) patients in the acute hemorrhagic period with unstable vital signs; and (3\) patients with poor heart, lung, liver or kidney functions. The patient characteristics, laboratory information and perioperative characteristics were recorded from the electronic medical records.

Outcomes

Primary Outcomes

Not specified

Similar Trials